Clusters of Intragenic Alu Repeats Predispose the Human C1 Inhibitor

Clusters of Intragenic Alu Repeats Predispose the Human C1 Inhibitor

Proc. Natl. Acad. Sci. USA Vol. 87, pp. 1551-1555, February 1990 Genetics Clusters of intragenic Alu repeats predispose the human C1 inhibitor locus to deleterious rearrangements (genetic disease/hereditary angioedema/serine protease inhibitor/complement) DOMINIQUE STOPPA-LYONNET*, PHILIP E. CARTERt, TOMMASO MEO*, AND MARIO TOSI*t *Unitd d'Immunogdndtique and Institut National de la Santd et de la Recherche Mddicale, U. 276, Institut Pasteur, Paris, France; and tDepartment of Biochemistry, University of Aberdeen, Aberdeen, United Kingdom Communicated by Donald C. Shreffler, October 30, 1989 (receivedfor review June 20, 1989) ABSTRACT Frequent alterations in the structure of the 5' half of the gene§ in a significant proportion of type I complement component C1 inhibitor gene have been found in families (9). Here we describe a "hot spot" of genetic patients affected by the common variant of hereditary angio- alterations, related to unusual Alu repeat clusters, which edema, characterized by low plasma levels ofC1 inhibitor. This accounts for the occurrence of the disease in a significant control protein limits the enzymic activity of the first compo- fraction of families. nent of complement and of other plasma serine proteases. Sequence comparisons of a 4.6-kilobase-long segment of the normal gene and the corresponding gene segments isolated EXPERIMENTAL PROCEDURES from two patients carrying family-specific DNA deletions point We examined gene alterations characteristic offour unrelated to unusually long clusters oftandem repeats oftheAlu sequence kindreds affected by type I HAE (families F1, F3, F4, and family as a source of genetic instability in this locus. Unequal F5). The disease-related restriction fragments found in fam- crossovers, in a variety ofregisters, amongAlu sequences ofthe ilies F1, F3, and F4 have been described (9). clusters result in deletions of variable length that encompass DNA Blot-Hybridization Analysis. The probes used were exon 4. In a third family, exon 4 was instead found to be either the entire insert of plasmid pHC1-INH/1 (10) or a Pst duplicated along with the same tracts offlanking introns lost in I fragment thereof. An exon 4-specific probe was produced by one of the deletions. In addition to undergoing Alu-mediated polymerase chain reaction (11) using a full-length cDNA clone partial deletions and duplications, the gene is also a target for kindly provided by S. Bock (12). DNA fragments were radio- more recent retroposition events. Gross alterations in the C1 actively labeled by using a random priming protocol (13). inhibitor gene account for about 20% of the hereditary an- Cloning and Characterization of Defective Genes. Genomic gioedema chromosomes and consequently make this gene a libraries were constructed from the DNA of member IV2 of prime example of the mutagenic liability of Alu repeats. family F1 and from a patient of family F4, both reported on previously (9), by using the bacteriophage A FIX vector The serine protease inhibitor complement component C1 (Stratagene). About one million phages from each library inhibitor (Cl INH) plays a key role in the control of the were plated on Escherichia coli strain C600 and screened classical pathway of complement activation, since it is the with the exon 4- to 8-specific cDNA probe. Four positive only inhibitor of the enzymic subcomponents Clr and Cis of clones were purified from each library and analyzed by C1, the first complement component (1). Furthermore, C1 double digestion with the INH also inactivates the seine proteases kallikrein, plasmin, enzymes Sal I and BamHI. and coagulation factors XIa and XIIa (reviewed in ref. 2). Sequencing Strategies. A detailed restriction map of the The most severe consequence of C1 INH deficiency, be it portion of the normal C1 INH gene extending from the due to impaired biosynthesis or to the presence of a dysfunc- BamHI site in exon 3 to the 3' boundary of exon 6 (see Fig. tional form, is uncontrolled complement component C1 activ- 2) was established by using subcloned fragments of cosmid ity with subsequent excessive cleavage of C2, the second clone 6d (14). To define the boundaries of the family-specific complement component (2). A C2-derived peptide, recently deletions found in families F1 and F4, appropriate fragments, shown to enhance vascular permeability (3), is believed to be outlined in Fig. 2, were sequenced in M13 vectors by using the main inducer ofthe swelling attacks typical ofangioedema single-strand (15) or double-strand (16) deletion protocols and (4). The hereditary form of angioedema (HAE) is a disease the modified dideoxy method (17). transmitted as an autosomal dominant trait (5, 6). Defects in the reactive site of the C1 INH protein, recently documented RESULTS in molecular terms (7, 8), often explain the forms ofthe disease in which a dysfunctional protein, which can sometimes accu- Family-Specific Deletions. DNA blot analyses of HAE type mulate to levels even higher than normal is synthesized (type I kindreds showed that partial C1 INH gene rearrangements II HAE). In contrast, little is known about the molecular are probably the single most frequent class ofgenetic lesions nature of the gene defects that are responsible for the more in the pathogenesis of HAE (9). To localize more precisely common form of HAE (type I), characterized by low serum such structural alterations, we studied the DNA of affected levels of normal C1 INH protein (6). members of unrelated families by using the enzyme BamHI Previous studies oftype I HAE families by using molecular and overlapping hybridization probes. Fig. 1 demonstrates probes for the C1 INH gene allowed us to show that DNA that several family-specific changes occur within the 6.9- length variations in this locus cosegregate with the disease. kilobase (kb)-long BamHI fragment comprising exons 3-6. The detection of family-specific sets of restriction fragments As expected from the dominant inheritance of the disease, led us to postulate that distinct alterations cluster within the Abbreviations: C1 INH, complement component C1 inhibitor; HAE, hereditary angioedema; IVS, intervening sequence (intron). The publication costs of this article were defrayed in part by page charge fTo whom reprint requests should be addressed. payment. This article must therefore be hereby marked "advertisement" §The sequence reported in this paper has been deposited in the in accordance with 18 U.S.C. §1734 solely to indicate this fact. GenBank data base (accession no. M30688). 1551 Downloaded by guest on October 8, 2021 1552 Genetics: Stoppa-Lyonnet et al. Proc. Nati. Acad. Sci. USA 87 (1990) Bg Bg Bg 1 2 3 4 5 6 1 M 'S ___ 1 - *jfl-' B B .i; B 4a e ,! B B 6.9 kr :A Probe exorns 4 8 .Bt Probe exoros 4 6 06 .b f)7ZZZZZt?..7Z7777i. atm4040 .0- - F. a kh = _ i--4.8 AM- ,; .b .' 1.F4 2 k b [1 N [3 F4 F4 F1 N F3 F4 F4 F1 : F. FIG. 1. DNA blot analysis ofdeletions in the 5' halfofthe C1 INH gene. Leukocyte DNA was digested with the BamHI endonuclease, FIG. 2. Isolation of normal and altered restriction fragments. The and the blot was hybridized with a probe covering most of the gene normal 6.9-kb BamHI fragment spanning exons 3-6 (rectangle (A) or with a probe specific for exons 4-6 (B). The autoradiogram marked "cosmid fragment"), derived from cosmid clone 6d (14), was compares the hybridization of a control DNA (N), of DNA from subcloned and sequenced on both strands. The normal 4.8-kb BamHl unrelated affected persons (F1 and F3), and of DNA from affected fragment covering intron IVS 6 and exon 7 was isolated from clone mother and daughter from a different family (F4). Note that in A the AF4.1, which represents the normal chromosome of the F4 patient. 6.9-kb band represents a doublet consisting of the fragment that Its central, stippled EcoRI fragment was sequenced as indicated by contains exons 3-6 and of the 3' terminal BamHI fragment. The the arrows. To define the boundaries of the deletions observed in diagram of the exon-intron structure and the restriction map are families F1 and F4, the 3.7- and 4.3-kb-long BamHI fragments, reproduced from ref. 14. Exon 1 is depicted as an open rectangle to derived from clones AF1 and AF4.2, respectively, were compared by indicate that the 5' end of the gene is not yet mapped precisely. Only restriction analysis to the corresponding normal 6.9-kb BamHI the BamHI (B) and BgI II (Bg) restriction sites are shown. fragment. The hatched 0.9- and 1.5-kb EcoRI-Sac I fragments, which encompass the boundaries of the deletions in families F1 and F4, the 6.9-kb hybridization band displays a reduced intensity in respectively, were sequenced and compared with the corresponding patients' DNA, consistent with their heterozygous genotype. normal sequence (4.6-kb-long hatched portion of the normal 6.9-kb difference is more prominent when the BamHI fragment). The stippled 1.7-kb EcoRI fragment of clone This quantitative 300 base pairs (open rectangle), exons 1B). In AF4.2 harbors an insertion of about shorter probe, specific for 4-6, is used (Fig. whose length is consistent with the presence ofan additional integral addition, each patient carries a shortened and family-specific Alu repeat (see Fig. 6). B, BamHl; E, EcoRI; S. Sac I. variant of the 6.9-kb-long BamHI fragment. The larger probe, specific for exons 4-8 (Fig. 1A), reveals observed in families F1 and F4 is shown in Fig. 3. A a 4.8-kb-long BamHI fragment common to normal individuals remarkable feature ofthe normal sequence is the presence of and patients, which however displays a reduced intensity in multiple tandemly arranged repeats of the Alu sequence the two members of family F4.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    5 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us